GlyT2 Antibodies

Santa Cruz Biotechnology features a diverse variety of GlyT2 monoclonal antibodies for research focused on understanding glycine transporter 2 (GlyT2). GlyT2 Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GlyT2 is crucial for the reuptake of glycine, an important neurotransmitter in the central nervous system, which plays a significant role in inhibitory neurotransmission and modulating synaptic activity. Dysregulation of GlyT2 has been implicated in several neurological disorders, making it a vital target for research aimed at understanding and potentially treating these conditions. The study of GlyT2 and its interactions can provide insights into synaptic function and the overall balance of excitatory and inhibitory signals in the brain. GlyT2 research has revealed important mechanisms in neurotransmitter regulation and synaptic plasticity. Understanding GlyT2 function continues to advance knowledge in neuroscience and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for GlyT2 enable researchers worldwide to advance scientific understanding of neurological processes and potential therapeutic applications.